BTIG analyst Carl Reichardt initiates coverage on Century Communities (NYSE:CCS) with a Neutral rating.
Analyst Expectations for Y-mAbs Therapeutics’s Future
Y-mAbs Therapeutics (NASDAQ:YMAB) has observed the following analyst ratings within the last quarter: Bullish Somewhat Bullish Indifferent Somewhat…